Pharma Focus Europe

LATEST NEWSRead more...

03

Jul 2024

Owkin Expands AI-Biotech Presence into Germany, Austria, and Switzerland to Enhance Research Acceleration

Owkin a prominent AIbiotech firm has expanded into the DACH region by forming partnerships with nine leading institutions These include Charit Universittsmedizin Berlin

02

Jul 2024

Radionetics Oncology and Lilly Enter Strategic Agreement

Radionetics Oncology a biotechnology company focused on developing innovative small molecule radiopharmaceuticals for targeting G proteincoupled receptors to treat solid tumors has announced a strategic partnership with Eli Lilly and Company The collaboration includes an upfront cash payment

02

Jul 2024

Signet Therapeutics receives FDA IND approval for the first targeted therapy designed for Diffuse Gastric Cancer

Signet Therapeutics a biotech company specializing in organoid disease models and AI for targeted cancer therapy announced FDA approval of its Investigational New Drug application for sigx

01

Jul 2024

Taurx Pharmaceuticals Has Applied for Marketing Authorisation in the UK for HMTM as an Alzheimer's Treatment

TauRx Pharmaceuticals Ltd has submitted a UK Marketing Authorisation Application for hydromethylthionine mesylate targeting mild cognitive impairment and mild

29

Jun 2024

Waypoint Bio Raises $14.5 Million to Enhance Drug Discovery Through in vivo Spatial Pooled Screening Technology

Waypoint Bio a biotechnology company has secured million in seed funding led by Hummingbird Ventures with participation from Recode Ventures and Fifty Years The company focuses on developing

29

Jun 2024

AQEMIA and Servier Reach Milestone in Immuno-Oncology Targeting Challenging Conditions

AQEMIA a leader in AIdriven drug discovery has achieved a significant research milestone in collaboration with Servier an international pharmaceutical company targeting an unmanageable

press releasesRead more...

Fresenius Continues its Biopharma Momentum with Launch of Subcutaneous Formulation of Tyenne® (tocilizumab-aazg) in the United States

Fresenius via its operating company Fresenius Kabi announced today the immediate availability in the US of its biosimilar Tyenne in a subcutaneous

Vertex Announces FDA Acceptance of New Drug Application for Vanzacaftor/Tezacaftor/Deutivacaftor, a Next-In-Class Triple Combination Treatment for Cystic Fibrosis

Vertex Pharmaceuticals Incorporated today announced that the US Food and Drug Administration has accepted its New Drug Application for investigational

Heron Therapeutics Announces Acceptance of the Prior Approval Supplement Application for ZYNRELEF® Vial Access Needle ("VAN")

Heron Therapeutics Inc a commercialstage biotechnology company today announced that the FDA acknowledged the receipt of the Companys Prior

Lilly's Kisunla™ (donanemab-azbt) Approved by the FDA for the Treatment of Early Symptomatic Alzheimer's Disease

The US Food and Drug Administration approved Kisunla Eli Lilly and Companys Alzheimers treatment for adults with early symptomatic Alzheimers disease which includes people with mild cognitive impairment as well as people

08 - 10

Jul 2024

18 - 20

Jul 2024

Pharma India Expo 2024

Telangana, India

29 - 31

Jul 2024

16 - 17

Aug 2024

iPharma Expo 2024

Boston, USA

22 - 24

Aug 2024
Thermo Fisher Scientific - mRNA Services
World Orphan Drug Congress 2024
World Vaccine Congress Europe 2024
Advanced Therapies USA 2024
cytiva

TOP ARTICLES

  • 1

    Pharmaceutical Marketing in the Digital Age: Strategies and Challenges

    Kate Williamson

    Kate, Editorial Team at Pharma Focus Europe, leverages her extensive background in pharmaceutical communication to craft insightful and accessible content. With a passion for translating complex pharmaceutical concepts, Kate contributes to the team's mission of delivering up-to-date and impactful information to the global Pharmaceutical community.

     

  • 2

    The Role of Technology in Enhancing Patient Acceptance and Satisfaction

    Kate Williamson

    Kate, Editorial Team at Pharma Focus Europe, leverages her extensive background in pharmaceutical communication to craft insightful and accessible content. With a passion for translating complex pharmaceutical concepts, Kate contributes to the team's mission of delivering up-to-date and impactful information to the global Pharmaceutical community.

     

  • 3

    Innovative Solutions: Cell and Gene Therapy's Impact on Pharma

    Kate Williamson

    Kate, Editorial Team at Pharma Focus Europe, leverages her extensive background in pharmaceutical communication to craft insightful and accessible content. With a passion for translating complex pharmaceutical concepts, Kate contributes to the team's mission of delivering up-to-date and impactful information to the global Pharmaceutical community.

     

  • 4

    Drug Safety in Focus: Challenges and Solutions for Pharma Companies

    Kate Williamson

    Kate, Editorial Team at Pharma Focus Europe, leverages her extensive background in pharmaceutical communication to craft insightful and accessible content. With a passion for translating complex pharmaceutical concepts, Kate contributes to the team's mission of delivering up-to-date and impactful information to the global Pharmaceutical community.

     

  • 5

    Medical Devices and Pharma: A Symbiotic Relationship for Improved Healthcare

    Kate Williamson

    Kate, Editorial Team at Pharma Focus Europe, leverages her extensive background in pharmaceutical communication to craft insightful and accessible content. With a passion for translating complex pharmaceutical concepts, Kate contributes to the team's mission of delivering up-to-date and impactful information to the global Pharmaceutical community.

     

KNOWLEDGE BANK

EDITORIAL SECTION